Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment

Journal of Alzheimer's Disease

Volumn 34, Issue 1, 2013, Pages 145-154

  Dwyer, Rebecca ^a   Skrobot, Olivia Anna ^a   Dwyer, James ^a   Munafo, Marcus ^a   Kehoe, Patrick Gavin ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Association; cognitive impairment; dementia; gene; meta analysis; vascular

Indexed keywords

ACE GENE; ACT GENE; APOE GENE; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; COHORT ANALYSIS; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MTHFR GENE; PON1 GENE; PRIORITY JOURNAL; PSEN 1 GENE; PUBLICATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VASCULAR COGNITIVE IMPAIRMENT;

EID: 84874341014     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121069     Document Type: Article

References (47)

1. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, Obrien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, Decarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology 43, 250-260. (Pubitemid 23060253)
2. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST (2003) Vascular cognitive impairment. Lancet Neurol 2, 89-98. (Pubitemid 37443329)
3. Roman GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, Lopez-Pousa S, Arizaga R, Wallin A (2004) Vascular cognitive disorder: A new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226, 81-87. (Pubitemid 39505412)
4. Roman GC (2002) Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 203, 7-10. (Pubitemid 35287368)
5. Kester MI, Scheltens P (2009) Dementia: The bare essentials. Pract Neurol 9, 241-251.
6. Adib-Samii P, Brice G, Martin RJ, Markus HS (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: Study in 200 consecutively recruited individuals. Stroke 41, 630-634.
7. Fukutake T (2011) Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): From discovery to gene identification. J Stroke Cerebrovasc Dis 20, 85-93.
8. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
9. Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Metaanalysis of genetic studies in ischemic stroke -Thirty-two genes involving approximately 18 000 cases and 58 000 controls. Arch Neurol 61, 1652-1661. (Pubitemid 39463422)
10. Sharma P (1998) Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 64, 227-230. (Pubitemid 28159806)
11. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K, Lalouschek W, Browner WS, Shi Y, Ringelstein EB, Kessler C, Luedemann J, Lindpaintner K, Liu L, Ridker PM, Zee RYL, Cook NR, Consortium RMSSS (2009) A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations association of lymphotoxinalpha in nonhypertensive patients. Stroke 40, 683-695.
12. Stankovic S, Majkic-Singh N (2010) Genetic aspects of ischemic stroke: Coagulation, homocysteine, and lipoprotein metabolism as potential risk factors. Crit Rev Clin Lab Sci 47, 72-123.
13. Markus HS (2010) Unravelling the genetics of ischaemic stroke. Plos Med 7, 1-6.
14. Liu H, Liu M, LiW, Wu B, Zhang SH, Fang Y, Wang Y (2009) Association of ACE I/D gene polymorphism with vascular dementia: A meta-analysis. J Geriatr Psychiatry Neurol 22, 10-22.
15. Liu H, Yang M, Li G-M, Qiu Y, Zheng J, Du X, Wang J-L, Liu R-W (2010) The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis. J Neurol Sci 294, 74-80.
16. Liu X, Li L, Liu F, Deng S, Zhu R, Li Q, He Z (2012) ApoE gene polymorphism and vascular dementia in Chinese population: A meta-analysis. J Neural Transm 119, 387-394.
17. Schrijvers EMC, Schuermann B, Koudstaal PJ, van den Bussche H, Van Duijn CM, Hentschel F, Heun R, Hofman A, Jessen F, Koelsch H, Kornhuber J, Peters O, Rivadeneira F, Ruether E, Uitterlinden AG, Riedel-Heller S, Dichgans M, Wiltfang J, Maier W, Breteler MMB, Ikram MA (2012) Genome-wide association study of vascular dementia. Stroke 43, 315-319.
18. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
19. Ioannidis JPA, Ntzani EE, Trikalinos TA (2004) 'Racial' differences in genetic effects for complex diseases. Nat Genet 36, 1312-1318. (Pubitemid 39577941)
20. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42, 473-480.
21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634. (Pubitemid 27387172)
22. Pfrieger FW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 60, 1158-1171. (Pubitemid 36791918)
23. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303.
24. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, Pessin MS (1996) Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27, 1333-1337. (Pubitemid 26286163)
25. Chalmers K, Wilcock GK, Love S (2003) APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 29, 231-238. (Pubitemid 36718171)
26. Bang OY, Kwak YT, Jool IS, Huh K (2003) Important link between dementia subtype and apolipoprotein E: A metaanalysis. Yonsei Med J 44, 401-413. (Pubitemid 36833891)
27. Liu B, Shen Y, Cen L, Tang Y (2012) Apolipoprotein E gene polymorphism in a Chinese population with vascular dementia: A meta-analysis. Dement Geriatr Cogn Disord 33, 90-95.
28. Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R, Berglund L (2006) Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res 47, 2475-2481. (Pubitemid 44936109)
29. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62, 1977-1983. (Pubitemid 38738207)
30. Beilby J, Rossi E (2000) Broadsheet number 58: Homocysteine and disease. Pathology 32, 262-273.
31. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354, 407-413. (Pubitemid 29355767)
32. Elkins JS, Johnston SC, Ziv E, Kado D, Cauley JA, Yaffe K (2007) Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in olderwomen.AmJ Epidemiol 166, 672-678. (Pubitemid 47347901)
33. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B, Spada R, Caraci F, Pourie G, Daval JL, Ferri R (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 15, 859-861. (Pubitemid 38453474)
34. Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A (2000) The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 48, 664-668. (Pubitemid 30390457)
35. Bi XH, Zhao HL, Zhang ZX, Zhang JW (2009) Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol Aging 30, 1601-1607.
36. Mansoori N, Tripathi M, Alam R, Luthra K, Ramakrishnan L, Parveen S, Mukhopadhyay AK (2010) IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi. Dement Geriatr Cogn Disord 30, 461-468.
37. Perla-Kajan J, Jakubowski H (2012) Paraoxonase 1 and homocysteine metabolism. Amino Acids 43, 1405-1417.
38. Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE (2000) Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1 (192) or PON1 (55) genotype. Arterioscler ThrombVasc Biol 20, 2441-2447.
39. Mendonca MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrao M, Ornelas I, Freitas S, Freitas C, Araujo JJ, Brehm A, Cardoso AA (2009) Gene-gene interaction affects coronary artery disease risk. Rev Port Cardiol 28, 397-415.
40. Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer's disease -friend or foe? Trends Neurosci 32, 619-628.
41. Ma J, Yee A, Brewer HB, Jr., Das S, Potter H (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer betaprotein into filaments. Nature 372, 92-94.
42. Kehoe PG, Russ C, McIlroy S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 21, 71-72. (Pubitemid 29036286)
43. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCM (2006) ACE Polymorphisms. Circ Res 98, 1123-1133. (Pubitemid 43948098)
44. Guan F, Gu J, Hu F, Zhu Y, Wang W (2012) Association between alpha1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a metaanalysis. Mol Biol Rep 39, 6661-6669.
45. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kolsch H, Heun R, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J (2012) The role of variation at AbetaPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis 28, 377-387.
46. Sterne JAC, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. J Clin Epidemiol 53, 1119-1129.
47. Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20, 439-444. (Pubitemid 39094573)